5/31/2021Sinovac to Set Up A National Vaccine R&D Center As Part of Related BRI...

5/31/2021AnHeart and Innovent Announce Exclusive License Deal for Taletrectinib...

5/31/2021Confronted by Demographic Challenges, Will China's Drug Market Prospec...

5/30/2021Pfizer's Vaccine Gets Caught in the Middle of China-Taiwan Fight

5/28/2021AffaMed Approved for Phase IIb Trial of AM006 in China for Parkinson's...

5/28/2021CStone's Sugemalimab Trial Met its Primary Endpoint with Upcoming Ch...

5/28/2021NMPA Issues the Provisions for Drug Inspection (Interim)

5/28/2021Recent Executive Moves

5/28/2021Review of Chinese Innovative Drug Research Failures

5/28/2021NHC: Health Statistics on Chinese Medical Care Providers and Patient V...

5/26/2021Sinovant and Nabriva Announce Positive Topline Results from Phase 3 T...

5/26/2021Shanghai Introduces New Policy to Enhance Development of Biopharma In...

5/26/2021AZ to Market Boan Biotech's Boyounuo (Bevacizumab Inj.) in Specific ...

5/26/2021Roche and TransTherato Evaluate Atezolizumab/TT-00420 Combo for GI Ca...

5/25/2021China and EU Held Pharmaceutical Regulatory Dialogue over Video Confer...

5/25/2021China Drug Patent Registration System (Orange Book) Opened For Testing

5/25/2021Patent Term Extension Introduced by the Fourth Amendment to the Chines...

5/24/2021Nicholas Hall Reports Slower Chinese CHC and OTC GI Market Growth in 2...

5/24/2021PPD Opens Clinical Research Lab in Suzhou

5/24/2021BeiGene, Novartis Report Promising Topline Results of Tislelizumab ...

5/24/2021Akeso Submits BLA for Penpulimab mAb in the U.S.

5/21/2021Everest Med Granted Priority Review for Sacituzumab Govitecan-hziy in ...

5/21/2021CARsgen Plans $157M Cancer Cell Therapy Facility in North Carolina

5/21/2021US Professor with China Ties Jailed for Lying on Grant Applications

5/21/2021Bayer's NDA for Its "Tumor Agnostic" Cancer Drug Vitravki (Larotrecti...

5/21/2021Recent Executive Moves

5/20/2021China Briefing: Five Takeaways for Foreign Investors from China's Cens...

5/19/2021InnoCare Approved of Clinical Trial of TYK2 Inhibitor ICP-332 in China

5/19/2021Antengene and Calithera Bio Enter into Worldwide Exclusive License Dea...

5/19/2021Chinese Hospitals Create Alliance to Enhance Children's Mental Health

Page:201/790 Total number of articles:23693: [First][<<] [199] [200] [201] [202] [203] [>>] [End]